NCT03121547View on ClinicalTrials.gov

Opioid Induced Gait Variability

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 19, 2015

Primary Completion Date

January 29, 2016

Study Completion Date

January 29, 2016

Conditions
Opioid Induced Motor Disturbances
Interventions
DRUG

Tapentadol 50 mg Oral Tablet

1 tablet administered

DRUG

Tramadol Hydrochloride 100 mg Extended Release Oral Tablet

1 tablet administered

DRUG

Placebo Oral Tablet

calcium tablet

Trial Locations (1)

2000

The Parker Institute, Frederiksberg Hospital, Copenhagen

All Listed Sponsors
lead

Frederiksberg University Hospital

OTHER

NCT03121547 - Opioid Induced Gait Variability | Biotech Hunter | Biotech Hunter